Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops prod... Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.15 | -7.73195876289 | 1.94 | 2.1675 | 1.65 | 103094 | 1.88961979 | CS |
| 4 | -1.34 | -42.8115015974 | 3.13 | 3.16 | 1.65 | 82275 | 2.15951652 | CS |
| 12 | -1.81 | -50.2777777778 | 3.6 | 5.95 | 1.65 | 71371 | 3.36640826 | CS |
| 26 | -2.356 | -56.825856247 | 4.146 | 5.95 | 1.65 | 50973 | 3.40139478 | CS |
| 52 | -3.01 | -62.7083333333 | 4.8 | 5.99 | 1.65 | 35471 | 3.71399301 | CS |
| 156 | -4.21 | -70.1666666667 | 6 | 9.6799 | 0.6706 | 357082 | 3.99392549 | CS |
| 260 | -24.81 | -93.2706766917 | 26.6 | 37.7 | 0.6706 | 590817 | 15.6174059 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
